Disclosures for "Characterizing the Swallow Tail Sign: A Cross-Sectional Clinicopathologic Analysis of the Pattern of Brain Atrophy in Autopsy-Confirmed Lewy Body Dementia"
-
Dr. Roche has nothing to disclose.
-
Dr. Sullivan has received personal compensation for serving as an employee of UT Health San Antonio. The institution of Dr. Sullivan has received research support from Baptist Health Foundation. The institution of Dr. Sullivan has received research support from NIH.
-
Dr. Chaudhari has nothing to disclose.
-
Dr. Salardini has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. The institution of Dr. Salardini has received research support from NIH/NIA. The institution of Dr. Salardini has received research support from Taylor Family. Dr. Salardini has received publishing royalties from a publication relating to health care.
-
Dr. Bieniek has nothing to disclose.
-
Dr. Flanagan has nothing to disclose.
-
An immediate family member of Dr. Parker has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Sanara Med Tech. An immediate family member of Dr. Parker has stock in Sanara Med Tech. An immediate family member of Dr. Parker has stock in Rochal Industries. An immediate family member of Dr. Parker has stock in Rochal Parnters. The institution of Dr. Parker has received research support from Texas Alzheimer's Research and Care Consortium. The institution of an immediate family member of Dr. Parker has received research support from Rochal Industries. An immediate family member of Dr. Parker has received intellectual property interests from a discovery or technology relating to health care.